Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)

Clinical trial NCT05722938 · RECRUITING

Trial details

NCT number: NCT05722938
Sponsor: Biotest
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Community-acquired Pneumonia

Start date: 2023-09-09
Primary completion: 2028-07-31
Enrollment: 590

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.